Compile Data Set for Download or QSAR
maximum 50k data
Found 1954 of ic50 data for complexid = 93
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM50593904(CHEMBL5198209)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of CDK4/Cyclin D1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253965(US9464092, EEE | US9527857, EEE)
Affinity DataIC50:  0.200nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253965(US9464092, EEE | US9527857, EEE)
Affinity DataIC50:  0.200nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM601953(2'-((4-(piperazine-1- carbonyl)phenyl)amino)-7',8'...)
Affinity DataIC50:  0.300nMAssay Description:Selected compounds disclosed herein were tested in kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM611019(US10626107, Example A crystal form of compound WX_...)
Affinity DataIC50:  0.350nMAssay Description:The standard Lance Ultra method was performed by a 10 μL enzyme reaction system containing 0.5 nM CDK2/cyclin A protein, 100 nM ULight-MBP polyp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253910(US9464092, B | US9527857, B)
Affinity DataIC50:  0.400nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253910(US9464092, B | US9527857, B)
Affinity DataIC50:  0.400nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253910(US9464092, B | US9527857, B)
Affinity DataIC50:  0.400nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM621179(US20230303564, Compound 21)
Affinity DataIC50:  0.460nMAssay Description:Preparation of Kinase Buffer: The composition of the buffer: 50 mM of hydroxyethylpiperazine ethanesulfonic acid solution at pH 7.5, 1 mM of ethylene...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253926(US9464092, R | US9527857, R)
Affinity DataIC50:  0.5nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253935(US9464092, AA | US9527857, AA)
Affinity DataIC50:  0.5nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253926(US9464092, R | US9527857, R)
Affinity DataIC50:  0.5nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM621180(US20230303564, Compound 22)
Affinity DataIC50:  0.5nMAssay Description:Preparation of Kinase Buffer: The composition of the buffer: 50 mM of hydroxyethylpiperazine ethanesulfonic acid solution at pH 7.5, 1 mM of ethylene...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253935(US9464092, AA | US9527857, AA)
Affinity DataIC50:  0.5nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253935(US9464092, AA | US9527857, AA)
Affinity DataIC50:  0.5nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253926(US9464092, R | US9527857, R)
Affinity DataIC50:  0.5nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM50593907(CHEMBL5178590)
Affinity DataIC50:  0.550nMAssay Description:Inhibition of CDK4/Cyclin D1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253925(US10189849, Compound 28 | US10927120, Compound 28 ...)
Affinity DataIC50:  0.600nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253925(US10189849, Compound 28 | US10927120, Compound 28 ...)
Affinity DataIC50:  0.600nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253925(US10189849, Compound 28 | US10927120, Compound 28 ...)
Affinity DataIC50:  0.600nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253925(US10189849, Compound 28 | US10927120, Compound 28 ...)
Affinity DataIC50:  0.627nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253925(US10189849, Compound 28 | US10927120, Compound 28 ...)
Affinity DataIC50:  0.627nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM50593909(CHEMBL5207372)
Affinity DataIC50:  0.650nMAssay Description:Inhibition of CDK4/Cyclin D1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253929(US9464092, U | US9527857, U)
Affinity DataIC50:  0.655nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253929(US9464092, U | US9527857, U)
Affinity DataIC50:  0.655nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253957(US10189849, Compound 39 | US10927120, Compound 39 ...)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253929(US9464092, U | US9527857, U)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253957(US10189849, Compound 39 | US10927120, Compound 39 ...)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253929(US9464092, U | US9527857, U)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253957(US10189849, Compound 39 | US10927120, Compound 39 ...)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253918(US9464092, J | US9527857, J)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253929(US9464092, U | US9527857, U)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253918(US9464092, J | US9527857, J)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253918(US9464092, J | US9527857, J)
Affinity DataIC50:  0.700nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253954(US9464092, TT | US9527857, TT)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253953(US9464092, SS | US9527857, SS)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253936(US9464092, BB | US9527857, BB)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253928(US10189849, Compound 27 | US10927120, Compound 27 ...)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM260525(US9527857, PPP)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253954(US9464092, TT | US9527857, TT)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253953(US9464092, SS | US9527857, SS)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253936(US9464092, BB | US9527857, BB)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253928(US10189849, Compound 27 | US10927120, Compound 27 ...)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253976(US9464092, PPP)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253954(US9464092, TT | US9527857, TT)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253953(US9464092, SS | US9527857, SS)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253936(US9464092, BB | US9527857, BB)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM253928(US10189849, Compound 27 | US10927120, Compound 27 ...)
Affinity DataIC50:  0.800nMAssay Description:Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM50593913(CHEMBL5174604)
Affinity DataIC50:  0.800nMAssay Description:Inhibition of CDK4/Cyclin D1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
The People'S Hospital Of Xinjiang Uyghur Autonomous Region

Curated by ChEMBL
LigandPNGBDBM50593905(CHEMBL5185047)
Affinity DataIC50:  0.800nMAssay Description:Inhibition of CDK4/Cyclin D1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 1954 total ) | Next | Last >>
Jump to: